CRINETICS PHARMACEUTICALS INC. - COMMON STOCK
56.28
25-November-24 09:08:07
15 minutes delayed
Stocks
+0.21
+0.38%
Today's range
55.93 - 57.42
ISIN
N/A
Source
NASDAQ
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 Feb 2023 16:21:42 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Participate in the SVB Securities Global Biopharma Conference
10 Feb 2023 07:01:33 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 Jan 2023 15:48:48 By Nasdaq GlobeNewswire
-
09 Jan 2023 07:01:39 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12 Dec 2022 15:01:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Provides Update on CRN04777 Program
28 Nov 2022 07:00:01 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Participate in the 5th Annual Evercore ISI HealthCONx Conference
22 Nov 2022 07:00:02 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
14 Nov 2022 07:00:02 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 Nov 2022 15:30:43 By Nasdaq GlobeNewswire
-
13 Oct 2022 07:00:02 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 Oct 2022 15:57:25 By Nasdaq GlobeNewswire
-
Innovation Passport Granted for CRN04777 for the Treatment of Congenital Hyperinsulinism
06 Oct 2022 07:00:02 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Appoints Dana Pizzuti, M.D. as Chief Development Officer
03 Oct 2022 07:00:01 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12 Sep 2022 07:00:01 By Nasdaq GlobeNewswire
-
08 Sep 2022 07:00:01 By Nasdaq GlobeNewswire
-
06 Sep 2022 07:00:02 By Nasdaq GlobeNewswire
-
02 Sep 2022 07:00:00 By Nasdaq GlobeNewswire
-
12 Aug 2022 07:00:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 Aug 2022 15:44:12 By Nasdaq GlobeNewswire
-
04 Aug 2022 07:00:01 By Nasdaq GlobeNewswire